Evaluation of the finnish diabetes risk score (FINDRISC) for diabetes screening in Kayseri, Turkey

dc.authorid0000-0003-4568-4234
dc.contributor.authorAtayoğlu, Ali Timuçin
dc.contributor.authorİnanç, Neriman
dc.contributor.authorBaşmısırlı, Eda
dc.contributor.authorÇapar, Aslı Gizem
dc.date.accessioned2020-10-16T06:53:33Z
dc.date.available2020-10-16T06:53:33Z
dc.date.issued2020
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Aile Hekimliği Ana Bilim Dalı
dc.description.abstractAim: Diabetes is a major health problem worldwide, as its prevalence is increasing dramatically. Lifestyle modification can delay or prevent the onset of type 2 diabetes. Therefore, screening for prediabetes and type 2 diabetes risk through an assessment of risk factors is important. The objective of the study was to investigate the risk for type 2 diabetes using the Finnish Diabetes Risk Score (FINDRISC) in Kayseri.Methods: In total, 1500 adults aged 18 years or older were interviewed using the FINDRISC as Diabetes Risk Questionnaire and fasting serum glucose levels. The findings of FINDRISC were grouped according to gender and a score of 15 and above was accepted as a high risk in terms of Type 2 diabetes.Results: 13.5% of the participants were in the high- risk group. There was a statistically significant relationship between total FINDRISC score and gender (p < 0.001). While 15.2% of the women were in the high -risk group, 12.4% of the men were in the high- risk group. The percentage of women in the low-risk group (35.9%) is less than the men with low- risk of diabetes (38.5%). As the BMI increased, the individuals were found to have a high risk evaluated with the use of FINDRISC. 14.3% of women with waist circumference >88 and 6.7% of men with waist circumference >102 were in the high- risk group. (p < 0.001)Conclusions: Risk of diabetes was found to be higher with the FINDRISC score as the BMI and waist circumference increased. FINDRISC can be used in the primary care for this purpose; fast and easy to be applied.
dc.identifier.citationAtayoğlu, A. T., İnanç, N., Başmısırlı, E. ve Çapar, A. G. (2020). Evaluation of the finnish diabetes risk score (FINDRISC) for diabetes screening in Kayseri, Turkey. Primary Care Diabetes, 14(5), 488-493. https://dx.doi.org/10.1016/j.pcd.2020.01.002
dc.identifier.doi10.1016/j.pcd.2020.01.002
dc.identifier.endpage493
dc.identifier.issn1751-9918
dc.identifier.issn1878-0210
dc.identifier.issue5
dc.identifier.scopusqualityQ2
dc.identifier.startpage488
dc.identifier.urihttps://dx.doi.org/10.1016/j.pcd.2020.01.002
dc.identifier.urihttps://hdl.handle.net/20.500.12511/5924
dc.identifier.volume14
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier Science Ltd
dc.relation.ispartofPrimary Care Diabetesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/embargoedAccess
dc.subjectDiabetes
dc.subjectFINDRISC
dc.subjectPrediabetes
dc.subjectPrevention
dc.subjectPrimary Care
dc.titleEvaluation of the finnish diabetes risk score (FINDRISC) for diabetes screening in Kayseri, Turkey
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
Atayoglu, A. Timucin-2020.pdf
Boyut:
491.49 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: